BBFY INDUSTRIAL supplier risk analysis Q1 2026: import footprint, sourcing profile, compliance overview.
BBFY INDUSTRIAL imported 202 shipments in Q1 2026 from 7 suppliers across 4 countries. Thailand dominated the sourcing footprint, accounting for 82.7% of shipments, followed by China at 10.9%. Sunshine Biotech served as the primary supplier with 196 combined shipments across multiple locations, including a dominant Thailand operation with 167 shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
No sanctions watchlist matches were detected for BBFY INDUSTRIAL in Q1 2026. No suppliers registered forced-labor exposure under UFLPA proximity screening.
7 distinct tier-1 suppliers in Q1 2026
| SUNSHINE BIOTECH | Thailand | 167 |
| SUNSHINE BIOTECH | China | 16 |
| SUNSHINE BIOTECH | Vietnam | 10 |
| ANHUI SEALONG BIOTECHNOLOGY | China | 4 |
| SUNSHINE BIOTECH | Singapore | 3 |
| ANHUI TIGER VITAMIN INDUSTRIAL | China | 1 |
| ANHUI TIGER BIOTECHNOLOGY | China | 1 |
Share of Q1 2026 inbound shipments by source country
5 tier-2 + 1 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.